|
C9ORF25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.003400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.640000E-01 |
| Normal-vs-Stage2 |
5.917900E-02 |
| Normal-vs-Stage3 |
7.144200E-02 |
| Normal-vs-Stage4 |
6.428400E-02 |
| Stage1-vs-Stage2 |
4.303700E-02 |
| Stage1-vs-Stage3 |
3.671700E-02 |
| Stage1-vs-Stage4 |
4.646100E-02 |
| Stage2-vs-Stage3 |
1.144380E-03 |
| Stage2-vs-Stage4 |
2.456300E-03 |
| Stage3-vs-Stage4 |
7.342600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.018400E-01 |
| Normal-vs-AfricanAmerican |
5.579800E-01 |
| Normal-vs-Asian |
2.394000E-01 |
| Caucasian-vs-AfricanAmerican |
1.701650E-01 |
| Caucasian-vs-Asian |
5.456500E-02 |
| AfricanAmerican-vs-Asian |
7.331000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.821800E-01 |
| Normal-vs-Female |
5.311400E-01 |
| Male-vs-Female |
6.610600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.594600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.097400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.612000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.508200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.230200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.811000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.877370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.881000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.827160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.922000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.39400000326506E-08 |
| Classical-VS-Follicular |
4.256200E-02 |
| Classical-VS-Other |
3.659800E-01 |
| Classical-VS-Normal |
8.592200E-01 |
| Tall-VS-Follicular |
1.35650002341947E-09 |
| Tall-VS-Other |
1.072770E-01 |
| Tall-VS-Normal |
5.33110000033865E-07 |
| Follicular-VS-Other |
1.346810E-01 |
| Follicular-VS-Normal |
1.183800E-01 |
| Other-VS-Normal |
1.959360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.203000E-01 |
| Normal-vs-N1 |
3.168200E-01 |
| N0-vs-N1 |
1.796430E-01 |
|
|
